Certara Corporation Acquires Specialty Contract Research Organization Synchrogenix

ST. LOUIS--(BUSINESS WIRE)--Certara™, the leading technology-enabled drug development and drug safety consultancy, announced today that it has acquired specialty contract research organization (CRO) Synchrogenix Information Strategies Inc. Synchrogenix offers regulatory writing and related services to pharmaceutical, biotechnology and medical device companies worldwide.

Help employers find you! Check out all the jobs and post your resume.